How Medicare drug pricing changes could affect commercial plans: 3 things to know

(By Rylee Wilson for Becker’s Hospital Review)

The drug-pricing provisions of the Inflation Reduction Act only apply directly to Medicare, but the new policies will have effects across the entire market, according to an analysis published Dec. 14 in Health Affairs. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org